Activin receptor type IIA/B blockade increases muscle mass and strength, but compromises glycemic...
Purpose Blocking the Activin receptor type IIA and B (ActRIIA/IIB) has clinical potential to increase muscle mass and improve glycemic control in obesity, cancer, and aging. However, the impact of...
biorxiv.org